Zealand Pharma A/S (ZEAL) — Financial Flexibility Index
Zealand Pharma A/S (ZEAL) has a Financial Flexibility Index of -0.63x as of December 2025. Free cash flow of Dkr-1.03 Billion (operating CF Dkr-1.04 Billion minus capex Dkr16.84 Million) represents -1% of total liabilities (Dkr1.63 Billion). Check Zealand Pharma A/S (ZEAL) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Zealand Pharma A/S Financial Flexibility Index (2007–2025)
Historical Financial Flexibility Index trend for Zealand Pharma A/S across 19 annual periods. For the full cash flow conversion analysis, see Zealand Pharma A/S (ZEAL) cash conversion ratio.
Annual Financial Flexibility Index for Zealand Pharma A/S (2007–2025)
Year-by-year free cash flow to debt coverage for Zealand Pharma A/S. Explore ZEAL operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (DKK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 4.02x | Dkr6.57 Billion | Dkr6.53 Billion | Dkr1.63 Billion | ▲ +489.9% |
| 2024 | -1.03x | Dkr-917.67 Million | Dkr-930.82 Million | Dkr888.86 Million | ▲ +0.6% |
| 2023 | -1.04x | Dkr-401.92 Million | Dkr-425.67 Million | Dkr387.15 Million | ▲ +19.2% |
| 2022 | -1.29x | Dkr-930.50 Million | Dkr-942.21 Million | Dkr723.89 Million | ▼ -23.1% |
| 2021 | -1.04x | Dkr-1.19 Billion | Dkr-1.21 Billion | Dkr1.14 Billion | ▼ -17.6% |
| 2020 | -0.89x | Dkr-663.67 Million | Dkr-688.72 Million | Dkr747.52 Million | ▲ +17.9% |
| 2019 | -1.08x | Dkr-385.94 Million | Dkr-409.45 Million | Dkr356.84 Million | ▲ +73.1% |
| 2018 | -4.02x | Dkr-456.36 Million | Dkr-460.40 Million | Dkr113.52 Million | ▼ -209.1% |
| 2017 | -1.30x | Dkr-271.52 Million | Dkr-278.75 Million | Dkr208.77 Million | ▼ -1344.9% |
| 2016 | 0.10x | Dkr43.50 Million | Dkr40.90 Million | Dkr416.43 Million | ▲ +118.0% |
| 2015 | -0.58x | Dkr-221.37 Million | Dkr-225.41 Million | Dkr382.46 Million | ▼ -428.2% |
| 2014 | -0.11x | Dkr-37.69 Million | Dkr-42.18 Million | Dkr343.93 Million | ▲ +98.0% |
| 2013 | -5.36x | Dkr-165.05 Million | Dkr-169.62 Million | Dkr30.77 Million | ▼ -317.6% |
| 2012 | 2.47x | Dkr77.39 Million | Dkr68.54 Million | Dkr31.39 Million | ▲ +616.1% |
| 2011 | 0.34x | Dkr9.67 Million | Dkr-1.81 Million | Dkr28.08 Million | ▲ +128.9% |
| 2010 | -1.19x | Dkr-51.74 Million | Dkr-55.98 Million | Dkr43.44 Million | ▲ +47.0% |
| 2009 | -2.25x | Dkr-57.88 Million | Dkr-61.45 Million | Dkr25.75 Million | ▼ -47.8% |
| 2008 | -1.52x | Dkr-25.25 Million | Dkr-28.62 Million | Dkr16.61 Million | ▲ +42.2% |
| 2007 | -2.63x | Dkr-55.20 Million | Dkr-57.57 Million | Dkr21.00 Million | — |